![](/images/graphics-bg.png)
Clinical Therapeutics in Pregnancy
Joint Authors
Mattison, Donald R.
Feghali, Maisa N.
Source
Journal of Biomedicine and Biotechnology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-07-06
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
Most drugs are not tested for use during pregnancy, consequently, labeling, which may include information about fetal safety, includes nothing about dosing, efficacy, or maternal safety.
Yet these are concerns of health care providers considering treatment of disease during pregnancy.
Therefore, the practitioner treats the pregnant woman with the same dose recommended for use in adults (typically men) or may decide not to treat the disease at all.
However, is the choice of not treating a woman during pregnancy better than dealing with the challenges which accompany treatment? This paper, which summarizes metabolic and physiologic changes induced by pregnancy, illustrates that standard adult dosing is likely to be incorrect during pregnancy.
American Psychological Association (APA)
Feghali, Maisa N.& Mattison, Donald R.. 2011. Clinical Therapeutics in Pregnancy. Journal of Biomedicine and Biotechnology،Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-497731
Modern Language Association (MLA)
Feghali, Maisa N.& Mattison, Donald R.. Clinical Therapeutics in Pregnancy. Journal of Biomedicine and Biotechnology No. 2011 (2011), pp.1-13.
https://search.emarefa.net/detail/BIM-497731
American Medical Association (AMA)
Feghali, Maisa N.& Mattison, Donald R.. Clinical Therapeutics in Pregnancy. Journal of Biomedicine and Biotechnology. 2011. Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-497731
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-497731